Skip to content

Bacteriotherapy to Improve Underarm Odor

Bacteriotherapy to Improve Underarm Odor

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03967470
Enrollment
67
Registered
2019-05-30
Start date
2018-10-01
Completion date
2022-12-30
Last updated
2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bromhidrosis

Brief summary

The goal is to improve the underarm odor by changing the microbiome. The autochthonous bacterial community is replaced by a non-smelling microbiome, by daily application of bacteria in a spray.

Detailed description

Participants are recruited and selected based on their initial underarm odor and underarm microbiome. The participants use two sprays: one spray containing the bacteria, and the other nothing (placebo). Participants do not know which spray they have. They use one spray during one month, and meanwhile take samples of their underarm microbiome (for sequencing), volatome (for GC/MS analysis) and odor (for odor panel analysis). Samples are stored in the freezer and brought to the university after one month, when they receive the second spray. The bacterial spray contains bacteria that are correlated with good underarm odor.

Interventions

BIOLOGICALBacterial spray

Bacterial spray containing bacteria that do not cause underarm malodor

Sponsors

University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Double blind: participants nor outcome assessors, odor panel or care providers do not know which spray they use.

Intervention model description

two groups of 30 people, one month of bacterial spray use and the other month placebo.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* above average underarm malodor * microbiome dominated with malodorous bacteria

Exclusion criteria

* not healthy * microbiome with too high levels of Staphylococcus

Design outcomes

Primary

MeasureTime frameDescription
Improved underarm odor1 monthOdor panel and GC/MS results provide insights on underarm odor development

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026